Differentially culturable tubercle bacteria as a measure of tuberculosis treatment response.

Saved in:
Bibliographic Details
Title: Differentially culturable tubercle bacteria as a measure of tuberculosis treatment response.
Authors: Peters JS; Department of Science and Innovation/National Research Foundation Centre of Excellence for Biomedical Tuberculosis Research, The National Health Laboratory Service, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., McIvor A; Department of Science and Innovation/National Research Foundation Centre of Excellence for Biomedical Tuberculosis Research, The National Health Laboratory Service, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Papadopoulos AO; Department of Science and Innovation/National Research Foundation Centre of Excellence for Biomedical Tuberculosis Research, The National Health Laboratory Service, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Masangana T; Department of Science and Innovation/National Research Foundation Centre of Excellence for Biomedical Tuberculosis Research, The National Health Laboratory Service, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Gordhan BG; Department of Science and Innovation/National Research Foundation Centre of Excellence for Biomedical Tuberculosis Research, The National Health Laboratory Service, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Waja Z; Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa., Otwombe K; Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa.; School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Letutu M; Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa., Kamariza M; Department of Biology, Stanford University, Stanford, CA, United States., Sterling TR; Vanderbilt University Medical Center, Nashville, TN, United States., Bertozzi CR; Department of Chemistry, Stanford University, Stanford, CA, United States.; Howard Hughes Medical Institute, Stanford University, Stanford, CA, United States., Martinson NA; Department of Science and Innovation/National Research Foundation Centre of Excellence for Biomedical Tuberculosis Research, The National Health Laboratory Service, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa.; Johns Hopkins University Center for TB Research, Baltimore, MD, United States., Kana BD; Department of Science and Innovation/National Research Foundation Centre of Excellence for Biomedical Tuberculosis Research, The National Health Laboratory Service, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Source: Frontiers in cellular and infection microbiology [Front Cell Infect Microbiol] 2023 Jan 12; Vol. 12, pp. 1064148. Date of Electronic Publication: 2023 Jan 12 (Print Publication: 2022).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Frontiers Media SA Country of Publication: Switzerland NLM ID: 101585359 Publication Model: eCollection Cited Medium: Internet ISSN: 2235-2988 (Electronic) Linking ISSN: 22352988 NLM ISO Abbreviation: Front Cell Infect Microbiol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2235-2988
DOI:10.3389/fcimb.2022.1064148